ArticleCancer medicine2024

Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.

Tadashi Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.